CN104524146A - Traditional Chinese medicine composition for prevention and adjuvant treatment of hypertensive, hyperlipidemia and hyperglycemia and application of traditional Chinese medicine composition - Google Patents

Traditional Chinese medicine composition for prevention and adjuvant treatment of hypertensive, hyperlipidemia and hyperglycemia and application of traditional Chinese medicine composition Download PDF

Info

Publication number
CN104524146A
CN104524146A CN201410764216.5A CN201410764216A CN104524146A CN 104524146 A CN104524146 A CN 104524146A CN 201410764216 A CN201410764216 A CN 201410764216A CN 104524146 A CN104524146 A CN 104524146A
Authority
CN
China
Prior art keywords
chinese medicine
medicine composition
parts
traditional chinese
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410764216.5A
Other languages
Chinese (zh)
Inventor
赵光学
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410764216.5A priority Critical patent/CN104524146A/en
Publication of CN104524146A publication Critical patent/CN104524146A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/60Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605Morus (mulberry)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00Tea; Tea substitutes; Preparations thereof
    • A23F3/34Tea substitutes, e.g. matè; Extracts or infusions thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236Ligusticum (licorice-root)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/46Eucommiaceae (Eucommia family), e.g. hardy rubber tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488Pueraria (kudzu)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708Rheum (rhubarb)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734Crataegus (hawthorn)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/884Alismataceae (Water-plantain family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8964Anemarrhena
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition for prevention and adjuvant treatment of hypertensive, hyperlipidemia and hyperglycemia and an application of the traditional Chinese medicine composition, belongs to the technical field of health care of traditional Chinese medicines, and provides a traditional Chinese medicine composition for prevention and adjuvant treatment of hypertensive, hyperlipidemia and hyperglycemia, which is accurate in effect, safe, low in price, and convenient to use, and an application of the traditional Chinese medicine composition in preparation of medicine preparations or tea bags for prevention and adjuvant treatment of hypertensive, hyperlipidemia and hyperglycemia as an active substance. The traditional Chinese medicine composition is prepared from the following raw materials: mulberry leaf, puerarin, hawthorn, eucommia leaf, rhizoma anemarrhenae, processed rhubarb, ginkgo leaf, rhizoma alismatis and ligusticum wallichii. With mulberry leaf, puerarin, hawthorn, eucommia leaf, rhizoma anemarrhenae, processed rhubarb, ginkgo leaf, rhizoma alismatis and ligusticum wallichii as main medicines, the traditional Chinese medicine composition has the efficacies of evacuating, relieving exterior syndrome, clearing away heat and toxic materials, inducing diuresis to alleviate edema, and promoting blood circulation to remove blood stasis; with rheum officinale as an auxiliary medicine, the traditional Chinese medicine composition has the efficacies of purging and dredging collaterals; and the original medicine effects are synergistically enhanced through compatible application, thus the effects of prevention and adjuvant treatment of hypertensive, hyperlipidemia and hyperglycemia are achieved.

Description

A kind of prevention and auxiliary treatment " three-hypers disease " Chinese medicine composition and application thereof
Technical field
The invention belongs to Chinese medicine health-care technical field, particularly relate to prevention and auxiliary treatment " three-hypers disease " Chinese medicine composition and application thereof.
Background technology
Along with the change of growth in the living standard and rhythm of life, being called as the hypertension of " affluenza ", hyperglycemia and hyperlipidemia i.e. " three-hypers disease " becomes commonly encountered diseases, and particularly more than 50 years old late adult onset is higher." three-hypers disease " has become the main risk factor threatening human health and life, is three healthy large killers.The patient of " three-hypers disease " is generally by medication treatment or adjustment.For a long time, treatment hypertension must use oral medicine for a long time in a large number, general just exist the shortcomings such as dosage is large, onset is slow, side effect is large, especially in morning, namely drug effect decay time hypertensive patient is the most dangerous, although therefore a lot of hypertensive patient adheres to taking medicine, but still occurs " sudden death in morning ".Comparatively general to the effect of the medicine of three-hypers disease treatment at present, be difficult to effective blood sugar lowering, blood pressure lowering, blood fat reducing, people wish the medicine that good effect, drug effect are long, consumption is little, expense is low for this reason.Chinese medicine composition of the present invention and application thereof have the effect of auxiliary treatment, and also have the effect of prevention.
Summary of the invention
The technical problem to be solved in the present invention proposes a kind of definite effect, safety prevention inexpensive, easy to use and auxiliary treatment " three-hypers disease " Chinese medicine composition.
The technical scheme of technical solution problem of the present invention is, each crude drug of Chinese medicine composition and weight proportion are Folium Mori 6---27 parts, Radix Puerariae 6---27 parts, Fructus Crataegi 6---27 parts, Folium Eucommiae 6---27 parts, the Rhizoma Anemarrhenae 6---27 parts, Radix et Rhizoma Rhei (processed) 1---5 parts, Folium Ginkgo 1---5 parts, Rhizoma Alismatis 6---27 parts, Rhizoma Chuanxiong 3---9 parts.
The optimal technical scheme of technical solution problem of the present invention is: each crude drug of Chinese medicine composition and weight proportion are: Folium Mori 9---24 parts, Radix Puerariae 9---24 parts, Fructus Crataegi 9---24 parts, Folium Eucommiae 9---24 parts, the Rhizoma Anemarrhenae 9---24 parts, Radix et Rhizoma Rhei (processed) 2---4 parts, Folium Ginkgo 2---4 parts, Rhizoma Alismatis 9---24 parts, Rhizoma Chuanxiong 4---8 parts.
Another technical problem that the present invention will solve proposes prevention and auxiliary treatment " three-hypers disease " Chinese medicine composition as active substance for the preparation of the pharmaceutical preparation of prevention and auxiliary treatment " three-hypers disease " or prepare for the application in making tea.
Of the present invention for prevention and auxiliary treatment " three-hypers disease " Chinese medicine composition as active substance for the preparation of preventing and the pharmaceutical preparation of auxiliary treatment " three-hypers disease " or the application of making tea, described pharmaceutical preparation is oral formulations.
Of the present invention for prevention and auxiliary treatment " three-hypers disease " Chinese medicine composition as active substance for the preparation of preventing and the pharmaceutical preparation of auxiliary treatment " three-hypers disease " or the application of making tea, described oral formulations comprises tablet, capsule, granule and powder.
Of the present invention for prevention and auxiliary treatment " three-hypers disease " Chinese medicine composition as active substance for the preparation of prevention and the pharmaceutical preparation of auxiliary treatment " three-hypers disease " or the application of teabag, described teabag is used for preventing by by described and auxiliary treatment " three-hypers disease " traditional Chinese medicine composite co-grinding, pack and make.
Main component and the effect thereof of Chinese medicine composition of the present invention are as follows:
Folium Mori (" herbal classic "): be the dried leaves of Moraceae defoliation small arbor plant Mulberry, bitter in the mouth, sweet, cold in nature.Return lung, Liver Channel, there is dispelling wind and heat pathogens, liver heat removing and eyesight improving, effect of clearing away lung-heat and moistening for dryness.Modern pharmacological research proves that the main component of Folium Mori contains flavone, alkaloid, plant sterol, polysaccharides of Folium Mori etc.Main pharmacological: the effects such as blood pressure lowering, blood sugar lowering, blood fat reducing, cholesterol reducing, defying age, resisting fatigue, antithrombus formation and atherosclerosis.The effect that polysaccharides of Folium Mori has the rising of significant blood pressure lowering suppression blood pressure is rich in Folium Mori.Containing strengthening blood capillary, the flavones ingredient reducing blood viscosity in Folium Mori, the composition in addition containing LDL-lipoprotein oxidation in antibody in Folium Mori, so Folium Mori are while fat-reducing, improving hyperlipemia, has again the effect of prevention scheming infarction and cerebral hemorrhage.
Folium Ginkgo: be the dry leaves of Ginkgoaceae deciduous tree plant Ginkgo biloba, sweet in the mouth, hardship, puckery, property is put down, and returns lung meridian, there is astringing the lung, relieving asthma, removing dampness, pain relieving function, for diseases such as cough and asthma due to lung deficiency and hypertension, hyperlipidemia, coronary heart diseases and angina pectoris and cerebral vasospasms.Modern pharmacological research proves multiple components useful with health containing natural activity flavone and amarolide etc. in Folium Ginkgo, there is dissolving cholesterol, the effect of blood vessel dilating, has positive effect to improving disordered brain function, arteriosclerosis, hypertension, dizzy, tinnitus, headache, senile dementia, hypomnesis etc.Its diseases prevention, cure the disease, the value of body-building is early on the books in the Compendium of Material Medica of Ming Dynasty's Li Shizhen (1518-1593 A.D.).Detect through national health department and prove: drink Folium Ginkgo tea and obviously can reduce serum cholesterol, triglyceride and low-density blood lipoprotein, reduce the effect of depot lipid in body.Fat-reducing etc. for the adjustment of hyperlipidemia, the complementary control of diseases of cardiovascular and cerebrovascular systems patient such as hypertension and coronary heart disease and obese type crowd has good effect, is the desirable beverage of prophylactic treatment senile dementia.Be recognized in the worldly to control, the optimal ingredient of anti-cardiovascular and cerebrovascular disease.
Folium Eucommiae: be the dry leaves of the Eucommiaceae plant Cortex Eucommiae, warm in nature, sweet in the mouth, has invigorating the liver and kidney, strong waist knee joint, bone and muscle strengthening, antiabortive effect.Modern pharmacological research proves, the Cortex Eucommiae contains gutta-percha, eucommito, flavonoid, tannin etc.Have good hypotensive effect, the absorption of cholesterol can be reduced, it to essential hypertension and renal hypertension all powerful.
Radix Puerariae (" herbal classic "): be the dry root of pulse family perennial defoliation liana Herba Gelsemii Elegantis or Radix Puerariae rattan, taste is sweet, pungent, cool in nature.Return spleen, stomach warp.Have relieving muscles diaphoresis, antipyreticly to promote the production of body fluid, effect of rash, modern pharmacological research proves, Radix Puerariae contains flavonoid, is mainly puerarin, xylopuerarin, daidzin, daidzein etc., and containing much starch.Have antipyretic, reduce blood glucose, antioxidation, anticoagulation improve brain blood circulation, dilating coronary blood vessel and improve myocardial ischemia-anoxemia state, improve the effects such as brain blood circulation, blood fat reducing and blood pressure lowering.Brain, coronary artery can be expanded, increase brain, blood flow coronarius.Radix Puerariae flavone has protective effect to because of the myocardial ischemia reaction caused by pituitrin.
The Rhizoma Anemarrhenae (" herbal classic "): be the dry rhizome of the Liliaceae herbaceos perennial Rhizoma Anemarrhenae.Bitter in the mouth, sweet, cold in nature.Return lung, stomach, kidney channel.There is clearing away heat-fire, YIN nourishing moistens hot-tempered effect.Modern pharmacological research proves: the Rhizoma Anemarrhenae is containing Saponin, phlegmatic temperament, tannin, nicotinic acid, choline etc.The effect that there is antipyretic, calm, blood pressure lowering, blood sugar lowering, diuresis and eliminate the phlegm.
Fructus Crataegi (" Newly Revised Canon of Materia Medica "): be the mature fruit of Rosaceae machaka or dungarunga plant Fructus Pyri Pashiae, Fructus Crataegi or Crataegi cuneatae.First two is practised and is claimed " Fructus Crataegi ", and rear one is practised and claimed " Fructus Crataegi cuneatae " sour in the mouth, sweet, tepor.Return spleen, stomach, Liver Channel.There is promoting digestion and removing stagnation, the capable stagnant effect of dissipating blood stasis.Modern pharmacological research proves, Fructus Crataegi contains malic acid, citric acid, Crataegolic acid, oleanolic acid, Quercetin, lactone, glycoside, lipolytic enzyme, saccharide etc.Fructus Crataegi cuneatae is containing hyperin.Quercetin, chlorogenic acid, caffeic acid, Crataegolic acid, oleanolic acid, vitamin C, vitamin B2, tannin etc.Fructus Crataegi can significantly reduce serum cholesterol and triglyceride, effectively prevents and treats atherosclerosis; Fructus Crataegi also plays heart tonifying by strengthening myocardial contraction, increase cardiac output, coronary artery dilator blood vessel, increase coronary flow, reduction myocardial oxygen consumption etc. and prevents anginal effect.In addition, the total flavones in Fructus Crataegi has the effect of blood vessel dilating and lasting blood pressure lowering, and Fructus Crataegi also has the effect such as blood circulation promoting and blood stasis dispelling, energy digestion promoting, nourishing the liver degrease, blood pressure lowering, blood fat reducing, antioxidation, enhancing immunity, removing gastrointestinal tract noxious bacteria.Modern times are usually used in coronary heart disease, hyperlipidemia and hypertension etc.
The rhizome that Rhizoma Chuanxiong (" herbal classic ") is Umbelliferae herbaceos perennial Rhizoma Chuanxiong.Acrid in the mouth, warm in nature.Return liver, gallbladder, pericardium channel.There is blood-activating and qi-promoting, effect of wind-expelling pain-stopping.Modern pharmacological research proves, Rhizoma Chuanxiong master is containing volatile oil, alkaloid, phenolic substance, lactone, organic acid etc.Alkaloid is mainly ligustrazine etc.Ligustrazine energy coronary artery dilator, increase coronary artery blood flow, improve the blood oxygen supply of cardiac muscle, and reduce the oxygen consumption of cardiac muscle: the expansible cerebrovascular of ligustrazine, reduce vascular resistance, remarkable increase brain and LBF amount, improve microcirculation, can reduce surface activity of blood platelet, suppress platelet aggregation, antithrombotic, water decoction to the sedation of animal central nervous systems, and has obvious and lasting hypotensive effect.
Rhizoma Alismatis (" herbal classic "): be the tuber of the perennial limnocryptophyte Rhizoma Alismatis of Alismataceae.Sweet in the mouth, cold in nature.Return kidney, urinary bladder channel.There is effect of diuresis, clearing away damp-heat.Modern pharmacological research proves that Rhizoma Alismatis master is containing Alisol A, B etc., also containing alkaloid, volatile oil, vitamin B12 etc.Rhizoma Alismatis has blood fat reducing, anti-fatty liver, also has blood sugar lowering, the effect of diuresis.Modern times are used for the treatment of hyperlipidemia.
Radix Et Rhizoma Rhei (" herbal classic ") is Polygonaceae herbaceos perennial sorrel (Beijing University is yellow), the rhizome of Rheum tanguticum and RADIX ET RHIZOMA RHEI OFFICILALIS.Bitter in the mouth, cold in nature.Return spleen, stomach, large intestine, liver, pericardium channel.Have capture stagnant, removing pathogenic heat from blood and toxic substance from the body, eliminating blood stasis and inducing menstruation, promoting the function of the gallbladder to alleviate jaundice.(cook make then property delay, be Radix et Rhizoma Rhei (processed)) modern pharmacological research proves that Radix Et Rhizoma Rhei is containing anthraquinone derivative chrysophanic acid, emodin, physcione, chrysophanol, aloe-emodin, Senna Fructus A etc.Another containing tannin.Can large intestine be stimulated, increase the tension force of intestinal and wriggling, secretion increasing and produce discharge function, also have and reduce blood pressure and the effect of cholesterol etc.
The present invention's Folium Mori, Radix Puerariae, Fructus Crataegi, Folium Eucommiae, the Rhizoma Anemarrhenae, Rhizoma Alismatis, Folium Ginkgo, Rhizoma Chuanxiong are principal agent, have evacuation and induce sweat, heat-clearing and toxic substances removing, inducing diuresis to remove edema, effect of blood circulation promoting and blood stasis dispelling.Radix Et Rhizoma Rhei is accessory drugs, has the effect of rushing down lower Tongli, is made that original drug effect is mutually collaborative to be strengthened by compatibility application, thus reaches the effect of prevention and assisting in treating hypertension, hyperlipidemia, hyperglycemia.
The present invention is following advantage compared with prior art:
1, the raw material that the present invention selects is pharmacopeia has the medicine clearly acted on, and is also the plant of medicated diet homology, and utilize the comprehensive function of Chinese medicine to regulate blood glucose, the index of blood fat and cholesterol, makes it be tending towards normal value, without chemical addition agent, harmless to human non-toxic.
2, the present invention with natural Chinese herbal medicine for raw material, use safety, convenience.Medicine can rapidly by endovascular triglyceride, cholesterol, low-density lipoprotein Pseudobulbus Bletillae (Rhizoma Bletillae) heavy-metal residual thing after entering human body.
3, mixing after raw material pulverizing is packed as low dose of parcel by the present invention, only needs to soak with boiled water when drinking, convenient and swift.
The present invention carries out therapeutic effect to experiment patient and follows the trail of statistics, and record is for experiment patient 100 example, and wherein male patient has 60 examples, female's surname patient 40 example, the age all more than 40 years old, medicine time be 1 to 3 month not etc., total effective rate is 99%, and cure rate is 82%.
Experimental example 1
Symbol XX: female 65 years old, fat, suffer from hypertension, high blood, hyperglycemia about 7 years, long-term taking Western medicine is to maintain blood pressure normally before, but a drug withdrawal, blood pressure rises immediately, and blood fat, blood viscosity do not fall always; Go to a doctor on April 12nd, 2009, the conscious dizzy pain of patient, insomnia, uncomfortable in chest, breathe hard, constipation, myasthenia of limbs 1 week.Through having a medical check-up: blood pressure 110/160 millimetres of mercury, T-CHOL 260mg/dl monoglyceride 160mg/dl, flushing, red tongue with yellow fur, deep pulse.Namely the Tea containing traditional Chinese medicine that the embodiment of the present invention 3 is obtained is taken, 9 grams every bag, each use 2 bags adds after 250 milliliters of warm waters soak 10 minutes to be taken, taking 3 every day, taking Tea containing traditional Chinese medicine of the present invention after 3 months, through having a medical check-up: its blood pressure, blood fat, blood viscosity all reach normal index scope, malaise symptoms disappears completely, drug withdrawal is after 3 months, through having a medical check-up: its blood pressure, blood fat and blood viscosity all within the scope of normal level, there are no rise.
Experimental example 2
Wu XX: man 60 years old, suffer from hypertension, hyperlipidemia 5 years, once multiple Western medicine, Chinese patent drugs for treatment was taken during one's sickness, but unsatisfactory curative effect, medicine stops namely sending out, repeatedly occur starting dizziness, headache, uncomfortable in chest to take the obtained Tea containing traditional Chinese medicine of the embodiment of the present invention 5,9 grams every bag on June 15th, 2002, get 1 bag at every turn, add after 15 milliliters of warm waters soak 10 minutes and take, take 3 every day, take Tea containing traditional Chinese medicine of the present invention after 2 months, normal index scope is all reached through inspection blood pressure of having a medical check-up, blood fat, also irregularly taking now, its blood pressure stabilization, blood fat has no rising.
Experimental example 3
Be coated with XX: man 69 years old, suffer from hypertension, more than 10 years of hyperglycemia.Coordinate treatment by Chinese herbs poor effect through Western medicine, take Tea containing traditional Chinese medicine first half of the month of the present invention, patient starts to occur that dizzy pain increases the weight of, polyuria, become thin, visual deterioration, listless, weak.On inspection: blood pressure 110/170 millimetres of mercury, 24 mM/ls, blood glucose, deep pulse.The Tea containing traditional Chinese medicine taking the embodiment of the present invention 1 on the 15th obtained in JIUYUE in 2010 was cured after 3 months; Follow up a case by regular visits to after January and do not recur, Morning Blood Pressure 80/120 millimetres of mercury, health is obviously improved.
Embodiment 4
Old XX: man 45 years old, fat, over conscious nearly 2 years often dizzy, uncomfortable in chest, extremity are aching and tired, through having a medical check-up: blood pressure 100/150 millimetres of mercury, cholesterol 250mg/dl, triglyceride 155mg/d1, namely hypertension, hyperlipidemia is diagnosed as, take the obtained Tea containing traditional Chinese medicine of the embodiment of the present invention 2 on March 16th, 2011,9 grams every bag, each 1 bag of warm water 150 milliliters is soaked after 10 minutes and is taken, every day 3 times, cure after 2 months, through having a medical check-up: blood pressure, blood fat all recover normal, follow up a case by regular visits to and repeatedly do not recur so far.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is described in further details.
Embodiment 1
Folium Mori 25g, Radix Puerariae 25g, Fructus Crataegi 25g, Folium Eucommiae 25g, Rhizoma Anemarrhenae 25g, Radix et Rhizoma Rhei (processed) 5g, Folium Ginkgo 5g, Rhizoma Alismatis 25g, Rhizoma Chuanxiong 8g.
Mixing after being pulverized by above-mentioned raw materials, is packed as the pouch of 6 grams.Every day takes 1 after mixing it with hot water---and 2 bags.
Embodiment 2
Folium Mori 20g, Radix Puerariae 20g, Fructus Crataegi 20g, Folium Eucommiae 20g, Rhizoma Anemarrhenae 20g, Radix et Rhizoma Rhei (processed) 4g, Folium Ginkgo 4g, Rhizoma Alismatis 20g, Rhizoma Chuanxiong 7g.
Mixing after being pulverized by above-mentioned raw materials, is packed as the pouch of 9 grams.Every day takes 1 after mixing it with hot water---and 2 bags.
Embodiment 3
Folium Mori 12g, Radix Puerariae 12g, Fructus Crataegi 12g, Folium Eucommiae 12g, Rhizoma Anemarrhenae 12g, Radix et Rhizoma Rhei (processed) 2g, Folium Ginkgo 2g, Rhizoma Alismatis 12g, Rhizoma Chuanxiong 4g.
Mixing after being pulverized by above-mentioned raw materials, is packed as the pouch of 9 grams.Every day takes 1 after mixing it with hot water---and 2 bags.
Embodiment 4
Folium Mori 16g, Radix Puerariae 16g, Fructus Crataegi 16g, Folium Eucommiae 16g, Rhizoma Anemarrhenae 16g, Radix et Rhizoma Rhei (processed) 3g, Folium Ginkgo 3g, Rhizoma Alismatis 16g, Rhizoma Chuanxiong 6g.
Mixing after being pulverized by above-mentioned raw materials, is packed as the pouch of 6 grams.Every day takes 1 after mixing it with hot water---and 2 bags.
Embodiment 5
Folium Mori 9g, Radix Puerariae 9g, Fructus Crataegi 9g, Folium Eucommiae 9g, Rhizoma Anemarrhenae 9g, Radix et Rhizoma Rhei (processed) 1g, Folium Ginkgo 1g, Rhizoma Alismatis 9g, Rhizoma Chuanxiong 3g.
Mixing after being pulverized by above-mentioned raw materials, is packed as the pouch of 9 grams.Every day takes 1 after mixing it with hot water---and 2 bags.
The present invention's said " three-hypers " refers to hypertension, hyperglycemia (diabetes) and hyperlipidemia.

Claims (6)

1. a prevention and auxiliary treatment " three-hypers disease " Chinese medicine composition, it is characterized in that: each crude drug of Chinese medicine composition and weight proportion are Folium Mori 6---27 parts, Radix Puerariae 6---27 parts, Fructus Crataegi 6---27 parts, Folium Eucommiae 6---27 parts, the Rhizoma Anemarrhenae 6---27 parts, Radix et Rhizoma Rhei (processed) 1---5 parts, Folium Ginkgo 1---5 parts, Rhizoma Alismatis 6---27 parts, Rhizoma Chuanxiong 3---9 parts.
2. Chinese medicine composition according to claim 1, it is characterized in that: each crude drug of Chinese medicine composition and weight proportion are: Folium Mori 9---24 parts, Radix Puerariae 9---24 parts, Fructus Crataegi 9---24 parts, Folium Eucommiae 9---24 parts, the Rhizoma Anemarrhenae 9---24 parts, Radix et Rhizoma Rhei (processed) 2---4 parts, Folium Ginkgo 2---4 parts, Rhizoma Alismatis 9---24 parts, Rhizoma Chuanxiong 4---8 parts.
3. according to claim 1 and 2 for prevention and auxiliary treatment " three-hypers disease " Chinese medicine composition as active substance for the preparation of the application prevented and in the pharmaceutical preparation of auxiliary treatment " three-hypers disease " or teabag.
4. according to claim 3 for prevention and auxiliary treatment " three-hypers disease " Chinese medicine composition as active substance for the preparation of preventing and the pharmaceutical preparation of auxiliary treatment " three-hypers disease " or the application of making tea, it is characterized in that: described pharmaceutical preparation is oral formulations.
5. according to claim 4 for prevention and auxiliary treatment " three-hypers disease " Chinese medicine composition as active substance for the preparation of preventing and the pharmaceutical preparation of auxiliary treatment " three-hypers disease " or the application of making tea, it is characterized in that: described oral formulations comprises tablet, capsule, granule and powder.
6. according to claim 3 for prevention and auxiliary treatment " three-hypers disease " Chinese medicine composition as active substance for the preparation of prevention and the pharmaceutical preparation of auxiliary treatment " three-hypers disease " or the application of teabag, it is characterized in that: described teabag is by being prevented being used for described in claim 1 or 2 and auxiliary treatment " three-hypers disease " traditional Chinese medicine composite co-grinding, packing and make.
CN201410764216.5A 2014-12-04 2014-12-04 Traditional Chinese medicine composition for prevention and adjuvant treatment of hypertensive, hyperlipidemia and hyperglycemia and application of traditional Chinese medicine composition Pending CN104524146A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410764216.5A CN104524146A (en) 2014-12-04 2014-12-04 Traditional Chinese medicine composition for prevention and adjuvant treatment of hypertensive, hyperlipidemia and hyperglycemia and application of traditional Chinese medicine composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410764216.5A CN104524146A (en) 2014-12-04 2014-12-04 Traditional Chinese medicine composition for prevention and adjuvant treatment of hypertensive, hyperlipidemia and hyperglycemia and application of traditional Chinese medicine composition

Publications (1)

Publication Number Publication Date
CN104524146A true CN104524146A (en) 2015-04-22

Family

ID=52839902

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410764216.5A Pending CN104524146A (en) 2014-12-04 2014-12-04 Traditional Chinese medicine composition for prevention and adjuvant treatment of hypertensive, hyperlipidemia and hyperglycemia and application of traditional Chinese medicine composition

Country Status (1)

Country Link
CN (1) CN104524146A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105641536A (en) * 2016-04-08 2016-06-08 北京御心堂生物科技股份有限公司 Composition for improving immunity and treating three-high diseases as well as decoction and preparation method
CN106106740A (en) * 2016-06-22 2016-11-16 仕承生物工程(上海)有限公司 A kind of compositions reducing three-hypers disease
CN107149017A (en) * 2017-05-19 2017-09-12 万建军 A kind of gold tea for being used to recuperate under medical treatment the hypertension as caused by hyperlipemia and hyperglycaemia
CN109123655A (en) * 2018-08-23 2019-01-04 刘德平 A kind of special doctor's food and preparation method with three high crowd's generation meal regulatory functions
CN112205559A (en) * 2020-10-20 2021-01-12 山东贝隆杜仲生物工程有限公司 Composition containing eucommia ulmoides and mulberry leaves and application

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1336206A (en) * 2001-08-10 2002-02-20 戚晓峰 Health tea for preventing and treating hypertension, byperlipemia and high blood viscosity disease
CN101401601A (en) * 2006-10-18 2009-04-08 吴建生 Five-leaf tea for reducing blood pressure, blood fat and blood sugar

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1336206A (en) * 2001-08-10 2002-02-20 戚晓峰 Health tea for preventing and treating hypertension, byperlipemia and high blood viscosity disease
CN101401601A (en) * 2006-10-18 2009-04-08 吴建生 Five-leaf tea for reducing blood pressure, blood fat and blood sugar

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
吴中朝: "《吴中朝滋补中药150味》", 31 May 2012, 江苏科学技术出版社 *
徐佩英: "糖尿病合并高血压的临床特征及其中医证候", 《中国临床医学》 *
裴正学: "高血压病证治探析", 《中医药学刊》 *
高群服: "《万家偏方》", 28 February 2005, 解放军出版社 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105641536A (en) * 2016-04-08 2016-06-08 北京御心堂生物科技股份有限公司 Composition for improving immunity and treating three-high diseases as well as decoction and preparation method
CN106106740A (en) * 2016-06-22 2016-11-16 仕承生物工程(上海)有限公司 A kind of compositions reducing three-hypers disease
CN107149017A (en) * 2017-05-19 2017-09-12 万建军 A kind of gold tea for being used to recuperate under medical treatment the hypertension as caused by hyperlipemia and hyperglycaemia
CN109123655A (en) * 2018-08-23 2019-01-04 刘德平 A kind of special doctor's food and preparation method with three high crowd's generation meal regulatory functions
CN112205559A (en) * 2020-10-20 2021-01-12 山东贝隆杜仲生物工程有限公司 Composition containing eucommia ulmoides and mulberry leaves and application

Similar Documents

Publication Publication Date Title
CN102078402B (en) Traditional Chinese medicine composition for treating hypertension, hyperlipidemia and hyperglycemia
CN103099959B (en) Traditional Chinese medicine preparation for treating ulcerative colitis and preparation method thereof
CN104107349A (en) Chinese herbal medicine for three-hypers patients, and its administration method
CN104489516A (en) Health-preserving porridge capable of improving postoperative immune function of cancer paint and preparation method for health-preserving porridge
CN104524146A (en) Traditional Chinese medicine composition for prevention and adjuvant treatment of hypertensive, hyperlipidemia and hyperglycemia and application of traditional Chinese medicine composition
CN105031517A (en) Dendrobium officinale healthcare tea capable of reducing blood fat, blood sugar, and blood pressure and preparation method thereof
CN104958646A (en) Chinese medicinal preparation for relaxing bowels and preparation method thereof
CN101380452A (en) Preparation method of no-alcohol type Shexiang Qushu liquid oral preparation
CN104707004A (en) Medicine capable of reducing blood pressure
CN103960415A (en) Weight-losing health herbal tea and preparation method thereof
CN104921242A (en) Weight-reducing beverage and preparation method thereof
CN103798472A (en) Healthcare tea and healthcare life-maintaining preparation
CN105560984B (en) Traditional Chinese medicine composition capable of boosting qi and invigorating spleen
CN104666999A (en) Traditional Chinese medicine formula capable of reducing blood pressure
CN104474342A (en) Tea cream for drinking of people with high blood pressure, high blood sugar and hyperlipidemia and preparation method of tea cream
KR101490793B1 (en) Method of preparing tea composition, and tea composition therefrom
CN103055292A (en) Gallbladder heat medicine composition and preparation method thereof
CN102895352B (en) Pharmaceutical composition and application thereof
KR20130060950A (en) The korean traditional fermentation tea and the preparation thereof
CN104274697A (en) Polygonatum odoratum health-preserving Chinese herbal medicinal liquor and preparation method thereof
CN104707003B (en) The Chinese medicinal capsule for the treatment of hypertension, hyperlipidemia
WO2023189035A1 (en) Composition for preventing, improving, or mitigating kidney-deficiency-associated symptoms or conditions of skin, hair, and nails
CN105362940A (en) Hypolipidemic cholesterol-reducing healthcare oral solution and preparation method thereof
CN104666998A (en) Traditional Chinese medicine composition used for treating hypertension
CN105056073A (en) Traditional Chinese medicine preparation for treating arrhythmia and preparing method thereof

Legal Events

Date Code Title Description
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20150422

RJ01 Rejection of invention patent application after publication